approves TEVA for a non-substitutable generic by the end of the year
That's in my "less than 1% chance of happening" pot, along with that fantasy in the Israeli paper about the FDA being forced to withdraw MNTA's approval and assorted other unlikely happenings.
Market Data 
Markets 
AI
